# Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal

> **NCT01573052** · PHASE4 · COMPLETED · sponsor: **VA Salt Lake City Health Care System** · enrollment: 26 (actual)

## Conditions studied

- Alcohol Withdrawal

## Interventions

- **DRUG:** Chlordiazepoxide
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT01573052
- **Lead sponsor:** VA Salt Lake City Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573052, "Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01573052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*